Promising
TUDCA (Tauroursodeoxycholic Acid)
The prediction game
Call it: rising or fading?
Where does TUDCA (Tauroursodeoxycholic Acid) stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: C (mixed evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 6.7/10
TUDCA earns its score on a narrow, real strength: hepatobiliary support, bile flow, and a single solid metabolic signal, with weaker proof everywhere else. It makes sense when you have a specific liver, bile, or insulin-sensitivity question, can buy a quality product, and can track a concrete before-and-after marker. It makes far less sense as a general detox shortcut or as a way to out-supplement a liver you keep stressing with steroids, alcohol, or junk. ✅ Best for: People targeting bile flow, sluggish digestion, cholestasis-type concerns, or liver and insulin-sensitivity questions, ideally with bloodwork and a clinician in the loop. It fits best when you define the outcome in advance, use a verified product, and stop if the marker does not move. ❌ Avoid if: You are pregnant, take bile-acid or liver medications without medical clearance, or expect TUDCA to fix a healthy liver you are actively damaging. Skip it as a substitute for sleep, nutrition, training, or real medical care. Be especially careful with the ALS angle: AMX0035 (Relyvrio) combined taurursodiol with sodium phenylbutyrate, the PHOENIX Phase 3 trial failed in 2024, and Amylyx pulled the product, so do not treat old ALS optimism as proof that stand-alone TUDCA protects nerves.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 0.2%
- BioHarmony Score
- 6.7/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.